Modulation of the cGAS–STING signaling pathway has potential therapeutic benefits in different types of malignant tumors, and it is currently being investigated in numerous clinical studies, but its role in the development and progression of laryngeal cancer has not yet been investigated [13]. The gene discussed is CGAS; the disease is cancer.